Title : Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide.

Pub. Date : 2002 Nov

PMID : 12452453






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide. Doxorubicin BCL2 like 1 Homo sapiens